Watkins Tim
- SEC CIK
- 0002065965
In the past year, 4 open-market sale filings worth $322.6K and no purchases.
Current role at each company
- CTNM Contineum Therapeutics, Inc.CMO & Head of Developmentas of Jul 1, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $322.6K
- 4 filings
- Net
- −$322.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Watkins Tim as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 (view filing)7:04 PM ET | Jun 30 | 1 day | Watkins TimCMO & Head of Development | SSaleClass A Common Stock | −10.8K | $16.02 | −$173.6K | −54.7%8.96K after | 10b5-1 |
| Mar 2, 2026 (view filing) | Mar 2 | Same day | Watkins TimCMO & Head of Development | SSaleClass A Common Stock | −3.61K | $15.02 | −$54.2K | −100.0%0 after | 10b5-1 |
| Jan 30, 2026 (view filing) | Jan 28 | 2 days | Watkins TimCMO & Head of Development | SSaleClass A Common Stock | −3.61K | $14.18 | −$51.2K | −100.0%0 after | 2 lots10b5-1 |
| Dec 30, 2025 (view filing) | Dec 29 | 1 day | Watkins TimCMO & Head of Development | SSaleClass A Common Stock | −3.61K | $12.06 | −$43.5K | −100.0%0 after | 10b5-1 |